Posttranslational modifications are used by cells from all kingdoms of life to control enzymatic activity and to regulate protein function. For many cellular processes, including DNA repair, spindle function, and apoptosis, reversible mono-and polyADP-ribosylation constitutes a very important regulatory mechanism. Moreover, many pathogenic bacteria secrete toxins which ADP-ribosylate human proteins, causing diseases such as whooping cough, cholera, and diphtheria. Whereas the 3D structures of numerous ADP-ribosylating toxins and related mammalian enzymes have been elucidated, virtually nothing is known about the structure of protein de-ADP-ribosylating enzymes. Here, we report the 3D structure of human ADP-ribosylhydrolase 3 (hARH3). The molecular architecture of hARH3 constitutes the archetype of an all-␣-helical protein fold and provides insights into the reversibility of protein ADP-ribosylation. Two magnesium ions flanked by highly conserved amino acids pinpoint the active-site crevice. Recombinant hARH3 binds free ADP-ribose with micromolar affinity and efficiently de-ADP-ribosylates poly-but not monoADP-ribosylated proteins. Docking experiments indicate a possible binding mode for ADP-ribose polymers and suggest a reaction mechanism. Our results underscore the importance of endogenous ADP-ribosylation cycles and provide a basis for structure-based design of ADP-ribosylhydrolase inhibitors.
P
osttranslational modifications (PTMs) are covalent modifications of amino acid side chains in proteins that come in many different sizes and shapes, ranging from the simple addition of a phosphate group to complex multistep glycosylations. Enzyme-catalyzed PTMs allow rapid responses to environmental stimuli and play crucial roles in signal transduction. NAD-dependent ADP-ribosylation is a reversible PTM in which mono-and polyADP-ribosyltransferases (ARTs and PARPs) and ADP-ribosylhydrolases (ARHs) and poly(ADP-ribose) glycohydrolases (PARGs) catalyze amino acid-specific ADPribosylation and de-ADP-ribosylation, respectively ( Fig. 1 ) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . ADP-ribosylation has attracted attention because bacterial virulence factors, including diphtheria, cholera, and pertussis toxin, use it as part of their pathogenic mechanism (2, 11) . Mono-and polyADP-ribosylation have been recognized also as regulatory mechanisms in many cellular processes, including DNA-repair, chromatin decondensation, transcription, telomere function, mitotic spindle formation, and apoptosis (5) (6) (7) (8) (9) (10) 12) .
Several enzymes have been cloned that catalyze de-ADPribosylation of mono-or polyADP-ribosylated proteins (13) (14) (15) . Dinitrogenase-activating glycohydrolase (DRAG), an Arg-specific ARH from the phototrophic bacterium Rhodospirillum rubrum, regulates a key enzyme of nitrogen fixation (16) (17) (18) . The human genome encodes three DRAG-related proteins designated ARH1, ARH2, and ARH3 (19) , which are 357, 354, and 363 residues long, respectively. ARH1, like DRAG, specifically de-ADP-ribosylates proteins mono-ADP-ribosylated on arginine residues (20, 21) . ARH3 de-ADP-ribosylates polyADP-ribosylated proteins, albeit at only Ϸ10% of the activity observed for the PARG (21) , with which it shares little if any sequence similarity (19, 21) . ARH3 does not act on ADPR bonds formed with Arg, Asn, or Cys. The function of ARH2 remains elusive because it acts on neither any of these ADP-ribosylated residues nor on polyADPR (21) .
The 3D structures of numerous ADP-ribosylating toxins and of three toxin-related vertebrate ARTs (chicken PARP-1, mouse
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Fig. 1.
Posttranslational modification of proteins by reversible ADPribosylation. ARTs and PARPs transfer the ADP-ribose (ADPR) moiety from ␤-NAD onto specific amino acid side chains or onto ADPR moieties (X) of target proteins under the release of nicotinamide. This modification may lead to either activation or inactivation of the target protein. Protein-ADPribosylhydrolases (ARHs and PARGs) hydrolyze the ␣-glycosidic bond between ADPR and the side chain, thereby restoring normal protein function. X can be Arg, Asp, Cys, diphthamide, Glu, or ADPR. In the case of mono-ADPribosylation, R and RЈ are OH groups. In the case of polyADP-ribosylation, attachment of ADPR can take place at the R site (elongation) or at the RЈ site (branching). In mammals, two distinct subfamilies of ARTs (ART1-5, PARP1-17) and two distinct subfamilies of ARHs (ARH1-3, PARG) exist.
PARP-2, and rat ART2.2) have provided fascinating insights into the structure and function of ADP-ribosylating enzymes (22) (23) (24) (25) (26) (27) . In contrast, very little is known about the structure and function of the enzymes catalyzing protein de-ADP-ribosylation (18, 21, 28) . Here, we report the 3D structure of a de-ADP-ribosylating enzyme. Based on binding, docking, and mutagenesis studies, we are able to propose the substrate-binding mode and the reaction mechanism.
Results
Overall Structure. The 3D structure of hARH3 lacking the Nterminal 16 aa (M r ϭ 37,745 Da) was determined in two different crystal forms, one grown in the absence and the other in the presence of ADP, and refined to high resolution (1.6 Å). Data collection, phasing, and refinement statistics indicate that the structure is of excellent quality (Table 1; and see Table 3 , which is published as supporting information on the PNAS web site). All three protomers from the two different crystal forms superimpose well, with an r.m.s. deviation of 0.5 Å between the two crystal forms and of 0.6 Å for the two protomers from the monoclinic crystal form (Fig. 6 , which is published as supporting information on the PNAS web site). The main differences are found in four small loop regions. The overall structure of hARH3 is that of a compact all-␣-helical monomeric molecule containing 19 ␣-helices, with approximate dimensions of 53 ϫ 50 ϫ 62 Å 3 ( Fig. 2 A and B ; and see Fig. 7 , which is published as supporting information on the PNAS web site). Size-exclusion chromatography confirmed that the monomeric state of hARH3 seen in the crystal structures is also present in solution. The complete amino acid chain, except for an internal loop between Pro-46 and Glu-55, is well defined in the electron-density map. Both N and C termini are located on the same side of the molecule, Ϸ18 Å apart. Two bound Mg 2ϩ ions are located directly opposite of the termini in a cleft spanning the entire molecule. The core structure of hARH3 consists of four quasidomains, designated A, B, C, and D ( (Fig. 8A , which is published as supporting information on the PNAS web site). A structure-based sequence alignment of hARH3 and the 1T5J structure shows that 14 of the 19 ␣-helices align very well (Fig. 8B) . Considerable deviations are observed only in loop regions. The structural similarity suggests that the hypothetical protein Mj1187 is an ADP-ribosylhydrolase.
PSI-BLAST searches readily identify sequence relationships of ARH3 with ARH1, ARH2, 1T5J, DRAG, and Ͼ300 other proteins from many different pro-and eukaryotes but not from plants. The hits include the JI jellyfish lens crystallins (29) and the zebrafish SelJ selenoprotein (30) , indicating that the ARH fold may have been adopted to also serve structural functions. It is interesting to note, however, that neither PSI-BLAST nor secondary-structure prediction analyses revealed any sequence or structural resemblance of PARG to the ARH3͞DRAG protein family (28) . These findings indicate that PARG is likely to adopt a fold different from that of hARH3.
Active Site. The active site of hARH3 is defined by the position of two Mg 2ϩ ions located in adjacent metal-binding sites, which are only 3.8 Å apart. Both Mg 2ϩ ions are octahedrally coordinated with almost ideal geometry. Residues contacting the Mg 2ϩ ions (Table  2) are located on the loop adjacent to ␣-helix 1, directly before and on ␣-helix 2, and directly before and on ␣-helix 17 (Fig. 3A) . Asp-300 and one water molecule bridge both metal ions. Although ADP cannot be located in the electron-density map of the monoclinic crystal form, the active sites of the protomers in this crystal form are notably different from the one of the protomer in the orthorhombic crystal form obtained in the absence of ADP (Fig.  3B ). Asp-300, which lies at the bottom of the metal-binding site, is slightly shifted but still coordinates both Mg 2ϩ ions, whereas Glu-25, located on the surface of the molecule, moves by Ϸ1.8 Å. All attempts to soak the hARH3 crystals with ADPR, ADP, AMP, ribose-phosphate, ribose, or pyrophosphate resulted in immediate crystal destruction. Cocrystallization experiments with ADPR, ADP, ribose-phosphate, and ribose did not yield any protein crystal with ligand bound. Docking. Docking experiments of hARH3 with ADP-ribosyl-ADPR yielded four significant hits. In all of these, the first ADPR moiety, the interconnecting ribose, and the first phosphate group of the subsequent ADP-ribose moiety are in a virtually identical position. The 2Ј-hydoxyl group of the terminal ribose docked in the active-site cleft is in close proximity to one of the two Mg 2ϩ ions (Fig. 4A ), which might act as an electron sink to further increase the susceptibility of the anomeric carbon atom to a nucleophilic attack. The residues Glu-25, Asp-61, and Asp-298 are located within a 5 Å radius of the anomeric carbon. This ribose moiety and the adjacent pyrophosphate group show most of the interactions with the protein. Docking experiments with an ADPR monomer also yielded significant hits with the terminal ribose moiety slightly shifted toward the two Mg 2ϩ ions and the pyrophosphate group on almost identical position (data not shown). (data not shown). In accord with a previous study (21) , hARH3 de-ADP-ribosylated PARP-1 and other polyADP-ribosylated target proteins present in a crude preparation of DNA but not arginine monoADP-ribosylated proteins (Fig. 5B) . The possible role of the ADPR-binding residues identified in the docking experiments were probed by site-directed mutagenesis. Mutants E25A, E25Q, D61N, S132A, Y133A, N135A, H166Q, E259A, D298N, D298E, T301A, and T301S were expressed as soluble proteins with similar efficiencies as wild-type ARH3 in Escherichia coli (Fig. 5C ). Mutants D61N, S132A, H166Q, D298E, and T301A lacked detectable activity, and mutants E25A, E25Q, Y133A, and D298N showed minimal residual activity ( Fig. 5D ; and see Fig. 9 , which is published as supporting information on the PNAS web site). Mutants N135A and T301S showed partial loss of activity, whereas the replacement of residue E259 had little, if any, effect on enzyme activity ( Fig. 5D ; and see Fig. 9 , which is published as supporting information on the PNAS web site). Fig. 4B shows a surface representation of ARH3 in which residues are highlighted in red and green, respectively, that, when mutated, do or do not cause inactivation of enzyme activity (this study and ref. 21) (see also Table 4 , which is published as supporting information on the PNAS web site, for a summary of mutant phenotypes). Amino acids mutated in this study and in a recent study by Oka et al. (21) are highlighted in yellow and gray, respectively. Mg 2ϩ -coordinating residues are underlined. At its N terminus, the amino acid sequence of hARH3 is extended by 16 -20 aa when compared with ARH1, ARH2, or DRAG. The 18 Nterminal residues of ARH3 were replaced by two residues (M and A) for crystallization. Consequently, the numbering of amino acid residues here deviates by 16 from that used by Oka et al. (21) .
Discussion
The structure of hARH3 constitutes an archetype of a new protein structure family. The binuclear Mg 2ϩ center found in the active site ( Fig. 2) is a unique feature among the family of glycohydrolases (31) . The ARH fold is completely different from that of arginase (PDB ID code 1RLA) (32), which contains a binuclear Mn center and which has been used in a previous study as a model for DRAG (18) . PSI-BLAST analyses indicate that the new ARH fold is widely spread in nature and may serve various enzymatic (i.e., hydrolysis of protein-ADP-ribosyl and polyADP-ribosyl bonds) as well as structural functions (i.e., lens crystallins in jellyfish and zebrafish) (29, 30) . Importantly, the results of PSI-BLAST, structure prediction, and threading analyses do not show any significant similarities of the ARH fold to the catalytic domain of PARG, indicating that the ARH fold is not a useful model for PARG. The 3D structure of hARH3 and the proposed binding mode of the docked ADPR (Fig. 4) support our own (Fig. 5D ) and published biochemical data (18, 21, 33, 34) . In the hARH3 model with the docked ADP-ribosyl-ADPR, one of the Mg 2ϩ ions coordinates the 2Ј-hydroxyl group of the ribose carrying the scissile glycosidic linkage. Conceivably, this Mg 2ϩ ion could increase the propensity of the anomeric carbon atom for a nucleophilic attack by acting as an electron sink (Fig. 10 , which is published as supporting information on the PNAS web site). The pivotal role of the binuclear magnesium cluster for binding the ribose moiety would account for the metal dependence of ADP-ribosylhydrolase activities (18) . The ARH3 fold also provides a rationale for the observed properties of ARH3, ARH1, and DRAG mutants analyzed here (Fig. 5D ) and in previous studies (Table 4) . Residues implicated in binding of the proximal ADPR by our docking experiments (Fig. 4) were mutated and resulted in loss of enzyme activity, except for E259, whose potential interaction with the distal adenine evidently does not contribute significantly to binding. Substitution of the Mg 2ϩ -coordinating residues Asp-61, Asp-62, and Asp-298 by nonacidic amino acids resulted in a dramatic reduction of enzyme activity of hARH3 (Fig. 5D and ref. 21) , as did mutations of the corresponding residues Asp-60 and Asp-61 in rat ARH1 and Asp-243 in DRAG (18, 33) . In contrast, substitution of Asp-61 of hARH1 by another acidic residue (Glu) had only little, if any, effect on enzyme activity, consistent with a retained capacity to bind Mg 2ϩ (18, 33) . Substitution of Thr-301 by Ala also abolished enzyme activity, whereas the conservative substitution with Ser led to only partial loss of activity. The predicted role of residues Ser-132 and His-166 in pyrophosphate binding is consistent with the observed loss of enzyme activity of hARH3 mutants S132A and H166Q (Fig. 5D) , as reported also for mutants of the corresponding residues in DRAG (18) . Further, the ARH3 structure accounts for the finding that mutations of residues located far from the active site had little, if any, effects on enzyme activity, i.e., Glu-222, Glu-223, Glu-245, and Glu-246 in hARH3 (21); His-65, Arg-139, and Asp-285 in rat ARH1 (33) ; and His-142 and Glu-279 in DRAG (18) . A recent mutagenesis study of DRAG identified a region containing residues Val-98, Asn-100, and Cys-102 as a potential surface for regulating The main part of the interaction takes place at the terminal ribose moiety and at the subsequent pyrophosphate, whereas the rest of the molecule hardly interacts at all. Note that the mobile residue Glu-25 ( Fig. 3) and the residues Asp-61 and Asp-298 are positioned close to the anomeric carbon atom. (B) Surface view of ARH3. Mutants of residues highlighted in green showed wild-type enzyme activity. Mutants of residues highlighted in orange or red showed mildly and strongly reduced enzyme activities, respectively. The region highlighted in blue corresponds to a proposed regulatory region in DRAG (see Discussion).
DRAG activity, e.g., by affecting the association of DRAG with membranes (35) . In accord with this observation, the corresponding region of ARH3 (␣-helix 5) is located on the protein surface, near to but outside of the proposed ADPR-binding region.
Glycosidases typically contain an acidic amino acid residue that acts as a proton acceptor and thereby activates a water molecule to perform the nucleophilic attack on the scissile glycosidic bond (36) . The observed flexibility of residue Glu-25 in the two crystal forms of ARH3 (Fig. 3B) is compatible with a role of this residue in activating the nucleophilic water. Alternatively, this function might also be performed by the nearby acidic residues Asp-61 or Asp-298 (see Figs. 3 and 10) .
The biological functions of ARH3 and other de-ADPribosylating enzymes in mammalian cells remain to be clarified. There is a striking imbalance between the number of ADPribosylating and the number of de-ADP-ribosylating enzymes identified in mammals to date: Mammalian genomes typically encode 16-17 PARP-related and 4-6 ART2-related ADP-ribosyltransferases, but only three ARH-related and a single PARG-related ADP-ribosylhydrolases (19, 37) . The best characterized polyADPribosylpolymerases have been localized to the cell nucleus (PARP1 and PARP2, the tankyrases) and͞or cytosol (vault PARP and PARP-10); whereas the best characterized mono-ADP-ribosyltransferases are GPI-anchored (ART1 and ART2) or secreted ectoenzymes (ART5) (6, 38) . Moreover, biochemical data has been obtained for mono-and polyADP-ribosylation reactions in mitochondria (12, 39) . The amino acid sequence of ARH3 is extended N-terminally by 16-20 aa compared with ARH1, ARH2, and DRAG (19) . TargetP analyses (40) predict a mitochondrial localization for ARH3 and, indeed, an hARH3-GFP fusion protein colocalizes with mitochondrial markers in transfected cells (data not shown). These findings indicate that hARH3 might function as a mitochondrial enzyme.
In conclusion, we here report the 3D structure of a protein-de-ADP-ribosylating enzyme. Our results lend support to the notion that reversible ADP-ribosylation constitutes an important regulatory mechanism in mammalian cells. The archetype ARH fold presented here provides a useful basis for modeling the argininespecific protein ADP-ribosylhydrolases DRAG and ARH1. Finally, the knowledge of the hARH3 structure provides the basis for structure-guided mutagenesis of ARHs and for the design of ARH-inhibitors.
Materials and Methods
Protein Production and Crystallization. Production, purification, and crystallization of human ARH3 were performed as described (41) . Human PARP-1, ARH1, and ARH3 mutants were expressed as C-terminally His 6 -tagged proteins in E. coli and were purified by affinity chromatography on Protino Ni-TED columns (MachereyNagel, Düren, Germany). Mouse ART2.2 was expressed as a C-terminally FLAG-tagged protein and purified from E. coli periplasm by affinity chromatography on M2-matrix (Sigma, St. Louis, MO) as described (42) .
Mutational Studies. Site-directed mutagenesis (QuikChange, Stratagene, La Jolla, CA) was performed according to the manufacturer's instructions. Protein solubility in E. coli lysates and during purification was taken as an indicator of overall structural integrity, i.e., mutants that segregated into inclusion bodies or that precipitated during purification were excluded from further analyses (e.g., mutants N135H and H166A, see Fig. 5D, lanes 3 and 6) . lines BW7A and X12 (Deutsches Elektronen-Synchrotron, Hamburg, Germany). The raw data were reduced by using DENZO, SCALEPACK (43) , and TRUNCATE (44) . One Xe-derivatized crystal, measured at a wavelength of 1.5 Å, was used in a singlewavelength anomalous-diffraction experiment for phase determination (Table 1) . Substructure determination, phase calculation, solvent flattening, and model building were performed automatically by using SHELXD, MLPHARE, DM, and ARP͞wARP within the software pipeline AutoRickshaw (45) (46) (47) (48) . Structure refinement was done by using the program REFMAC5 (44).
Binding and Enzyme Assays. Isothermal titration binding assays were carried out at 16°C in a buffer containing 100 mM Tris, pH 8.0, 150 mM NaCl, and 2 mM MgCl 2 by using a VP-ITC instrument (Microcal, Northampton, MA). Ligands in the injection syringe were at a concentration of 1 mM, and the concentration of hARH3 was 0.05 mM. Thirty injections were performed with a 5-min delay between injections to allow the baseline to stabilize. To determine the heat of dilution, the same experiment was carried out by using only buffer as an injectant. Data were analyzed with Origin software (OriginLab, Northampton, MA). ADP-ribosylation of the M2 antibody by mouse ART2.2 and autoADP-ribosylation of PARP-1 in the absence or presence of salmon sperm DNA were performed in 50 l of PBS at 37°C. Reactions were initiated by the addition of 1 M [ 32 P]NAD [200 Ci͞mmol (1 Ci ϭ 37 GBq)]. After 40 min, ADP-ribosylated proteins were separated from unincorporated nucleotides by gel-filtration chromatography. Purified human ARH1 or human ARH3 were added at the indicated concentrations, and incubations were continued for 30-60 min at 37°C in PBS containing 10 mM MgCl 2 and 5 mM DTT. Reactions were stopped by the addition of SDS͞PAGE sample buffer. Reaction products were analyzed by SDS͞PAGE autoradiography. Docking Studies. The 3D ligand input file for ADP-ribosyl-ADPribose was generated with Sybyl (Sybyl 7.0; Tripos, St. Louis, MO) and optimized by energy minimization using the Conjugate Gradients method and the Tripos force field until the convergence criterion of 0.05 kcal͞(mol Å) was reached. The FlexX docking program (49) interfaced within Sybyl was used to dock the ligand to the active site of hARH3 to examine possible binding modes of ADPR. FlexX takes account of ligand conformational flexibility by an incremental fragment-placing technique. The active site of hARH3 was defined as all amino acids within 8-Å proximity of the residues Ser-22, Glu-25, Pro-46, Glu-55, Tyr-58, Gly-101, Ser-132, Phe-133, His-166, and Glu-255. All resulting docking conformations were ranked according to the CScore, and the best ranked docking conformations (CScore 5) were checked visually.
Database Searches and Structure Analyses. Position-sensitive iterative BLAST searches were performed with PSI-BLAST (50), secondary structure-matching searches with SSM [European Bioinformatics Institute (EBI), Hinxton, Cambridge, U.K.] and PSIPRED (51, 52) . Amino acid sequence alignments were performed with ClustalW and T-Coffee (53, 54), and structure-based sequence alignments were performed with STAMP (55) . The mitochondrial targeting signal sequence was predicted with TargetP (40) . Structure models were superimposed with LSQMAN (56) . Ribbon plots and hydrogen-bond presentations were prepared with MOLSCRIPT and Raster3D (57, 58) and surface presentations with GRASP (33) and PyMOL (44, 59) .
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